Capital expenditure · 2015–2025
Axsome Therapeutics capital expenditure
$480,000+77.8% · FY2025
Axsome Therapeutics (AXSM) reported $480,000 in capital expenditure for fiscal 2025, +77.8% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $480,000 | +77.8% | Open → |
| FY20242024-12-31 | $270,000 | −53.6% | Open → |
| FY20232023-12-31 | $582,000 | −17.1% | Open → |
| FY20222022-12-31 | $702,000 | +127.9% | Open → |
| FY20212021-12-31 | $308,000 | +571.2% | Open → |
| FY20202020-12-31 | $45,891 | +184.7% | Open → |
| FY20192019-12-31 | $16,121 | −50.7% | Open → |
| FY20182018-12-31 | $32,696 | +230.3% | Open → |
| FY20172017-12-31 | $9,898 | −90.5% | Open → |
| FY20162016-12-31 | $104,561 | +417.8% | Open → |
| FY20152015-12-31 | $20,195 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +37.3%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Axsome Therapeutics capital expenditure |url=https://companiesranked.com/en/company/axsome-therapeutics/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Axsome Therapeutics capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/axsome-therapeutics/capital-expenditureBibTeX
@misc{companiesranked-en-company-axsome-therapeutics-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Axsome Therapeutics capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/axsome-therapeutics/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-064267 · February 23, 2026
{{cite web |title=Axsome Therapeutics capital expenditure — 10-K (0001193125-26-064267) |url=https://www.sec.gov/Archives/edgar/data/1579428/000119312526064267/axsm-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-23}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.